top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
55700-0705-06 | Q0144 | AZITHROMYCIN DIHYDRATE, ORAL, CAPSULES/POWDER, 1 GRAM | AZITHROMYCIN 250 MG | PO |
57237-0075-30 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HCL (FILM-COATED) 4 MG | PO |
54868-3695-00 | J0736 | INJECTION, CLINDAMYCIN PHOSPHATE, 300 MG | CLINDAMYCIN PHOSPHATE (S.D.V.) 150 MG/1 ML | IJ |
54868-3695-00 | J3490 | UNCLASSIFIED DRUGS | CLINDAMYCIN PHOSPHATE (S.D.V.) 150 MG/ML | IJ |
54868-3826-00 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE 2.5 MG | PO |
54868-3826-01 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE 2.5 MG | PO |
54868-3826-03 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE SODIUM 2.5 MG | PO |
54868-3826-04 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE SODIUM 2.5 MG | PO |
54868-3826-05 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE SODIUM 2.5 MG | PO |
54868-3826-06 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE SODIUM 2.5 MG | PO |
54868-3826-07 | None | METHOTREXATE, 2.5 MG, ORAL | METHOTREXATE 2.5 MG | PO |
52959-0126-05 | J7512 | PREDNISONE, IMMEDIATE RELEASE OR DELAYED RELEASE, ORAL, 1 MG | PREDNISONE 10 MG | PO |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
